EUCTR2022-000427-20-NL进行中（未招募）1 期
A stable glucagon analog administered by a bihormonal closed loop system; a feasibility study - STABLE1
Inreda Diabetic0 个研究点目标入组 12 人开始时间: 2022年2月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosed with diabetes mellitus type 1;
- •Treated with the Inreda AP system for a minimum of 1 month;
- •Age between 18 and 75 years;
- •Adequate contraception is required (only applicable for female participants);
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 9
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 3
排除标准
- •Impaired awareness of hypoglycemia
- •Pregnancy and/or breastfeeding;
- •Use of oral antidiabetic agents;
- •Pheochromocytoma;
- •Insulinoma;
- •Severe liver/heart/renal failure;
- •Alcohol abuse;
- •Hypersensitivity reactions to dasiglucagon.
研究者
相似试验
撤回
2 期
A Stable Glucagon Analog Administered by a Bihormonal Closed Loop SystemDiabetes Mellitus, Type 1NCT05454709Inreda Diabetic B.V.
招募中
不适用
Investigation of the secretion of glucagon for glucose intoleranceormal glucose tolerance (NGT), Impaired glucose tolerance(IGT), Type 2 diabetes (T2DM)JPRN-UMIN000019252Kobe university school of medicine, Diabetes and Endocrinoplogy105
已完成
不适用
Alternation in glucagon secretion associated with progression of glucose intolerance.normal glucose tolerance, impaired glucose metabolism, Type 2 diabetes mellitus (non-insulin dependent)JPRN-UMIN000016133Kitasato University School of Medicine53
已完成
3 期
Glucose control through a bihormonal artificial pancreas in patients after total pancreatectomy for cancer (PANORAMA): multicenter randomized controlled cross-over trial - Dutch Pancreatic Cancer Group (DPCG)10018424diabetesNL-OMON53782Amsterdam UMC40
进行中（未招募）
不适用
Testing Whether Glucagon Solutions Affect the Glucose Levels in the Fat Tissue of Diabetic Patients.EUCTR2014-002341-22-ATMedizinische Universität Graz; Universitätsklinik für InnereMedizin; Abteilung für Endokrinologie und Stoffwechsel